BAY 60–6583
Names | |
---|---|
Preferred IUPAC name
2-({6-Amino-3,5-dicyano-4-[4-(cyclopropylmethoxy)phenyl]pyridin-2-yl}sulfanyl)acetamide | |
Other names
BAY 60–6583
| |
Identifiers | |
3D model (
JSmol ) |
|
ChemSpider | |
IUPHAR/BPS |
|
PubChem CID
|
|
UNII | |
| |
| |
Properties | |
C19H17N5O2S | |
Molar mass | 379.435 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
BAY 60–6583 is a selective adenosine A2B receptor agonist.[1] It has been shown to provide protection from ischemia (lack of oxygen due to blocked blood supply) in both the heart and kidney of test animals,[2][3] and has also been shown to be beneficial in treatment of acute lung and brain injury,[4][5] as well as claimed anti-aging and anti-obesity effects,[6] showing a range of potential applications for selective A2B agonists.
References